Clinical Trials Browser

Phase 1 × Iohexol × 90 days × Clear all

NCT03997370 2026-03-27

Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Phase 1 Active not recruiting

Other solid neoplasm

Malignant Solid Neoplasm

NCT04504331 2026-02-12

Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer

Phase 1 Terminated

4 enrolled 11 charts

Breast Neoplasms